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Thioredoxin-interacting protein (TXNIP)
has been linked to cell apoptosis and
inflammation in a number of diseases,
including type 2 diabetes (Shah et al.,
2013), atherosclerosis (Berk, 2007), and
myocardial ischemia (Yoshioka et al.,
2012). TXNIP has been identified as a
tumor suppressor gene and in cancer, a
loss of TXNIP can lead to cell prolifera-
tion (Zhou and Chng, 2013). The primary
role of TXNIP is inhibition of thiore-
doxin (TRX), an important redox pro-
tein and promoter of cell growth. TRX is
a ubiquitous protein that reduces thiols,
especially insulin disulfides, and controls
levels of reactive oxygen species (ROS)
in cells, limiting damage from oxidative
stress. Inhibition of TRX by TXNIP car-
ries lethal consequences for cells and can
promote destructive inflammation (Junn
et al., 2000; Spindel et al., 2012). In human
aortic endothelial cells with TXNIP knock-
down, cultured under high glucose condi-
tions to promote oxidative stress, there was
a decrease in the amount of ROS gener-
ated as compared with control cells. This
suggests that high levels of TXNIP inhibit
the redox activity of cytoplasmic thiore-
doxin (TRX1) correlating with increased
levels of ROS (Li et al., 2009). Mouse
mesangial cells from wild type (C3H)
and TXNIP-deficient mice (Hcb-19) were
exposed to high glucose. After 3 h, ROS
generation was 2.5–3 times greater in the
cells fromC3H compared to Hcb-19 (Shah
et al., 2013). Mitochondrial thioredoxin,
TRX2, like its cytoplasmic counterpart,
TRX1, was found to regulate ROS and
manage oxidative stress within mitochon-
dria. HeLa cells were transiently trans-
fected with a TRX2 expression vector
and when treated with tumor necrosis
factor alpha (TNF-a), a pro-inflammatory
cytokine, generated approximately 50%
less ROS than TNF-a treated control HeLa
cells (Hansen et al., 2006). In this opin-
ion piece, we interpret the facts on mito-
chondrial danger signaling: TXNIP’s role
in the mitochondria, interactions with
mitochondrial TRX2 and activation of
the NOD-like receptor protein 3 (NLRP3)
inflammasome [an oligomeric complex
activated by cellular infections or stress
(Schroder and Tschopp, 2010)] signaling
pathway not previously described.
While the role of TXNIP is defined,
details of its localization within the
cell remain unsolved. Based on previ-
ous research, which implicated TXNIP
in mitochondrial death signaling, Saxena
et al. explored the intracellular localiza-
tion of TXNIP. They found that it is
shuttled into mitochondria under oxida-
tive stress while it is found in the
nucleus under normal conditions (Saxena
et al., 2010). TXNIP and TRX2 inter-
actions were examined based on the
parallel roles of cytoplasmic TRX1 and
mitochondrial TRX2. Indeed, TXNIP and
TRX2 are bound within the mitochondria,
inhibiting the reductive power of TRX2,
thus leaving ROS levels unchecked. The
redox-regulated apoptosis-signal kinase
(ASK1), a member of the mitogen-
activated protein kinase family, has been
deemed an important link between cellular
stress and innate immunity (Barton and
Medzhitov, 2003; Kolliputi and Waxman,
2009). ASK1 is usually bound to TRX2
under basal conditions, however, during
stress and following TXNIP transloca-
tion to the mitochondria, ASK1-TRX2
binding is disrupted, triggering an apop-
totic signal cascade. Unbound ASK1 is
phosphorylated, signaling cytochrome C
release and caspase-3 cleavage, eventually
causing apoptosis (Bhattacharyya et al.,
2003).
Zhou et al. showed that ROS causes
TXNIP to associate with NLRP3 lead-
ing to inflammasome activation (Zhou
et al., 2011). This study suggests that
in the unstressed cell, TXNIP is bound
to TRX1 and is inactive. In response to
oxidative stress, ROS generation facil-
itates TRX1-TXNIP dissociation, thus
increasing NLRP3-TXNIP association.
Also, TXNIP translocates to the mito-
chondria, where it binds to TRX2 leading
to mitochondrial dysfunction. However,
the function of TRX2 in regulating the
inflammasome has not been studied
to determine whether it is an essential
component of NLRP3 activation. The
NLRP3 inflammasome, consists of NLRP3
oligomers and apoptosis-associated speck-
like (ASC) adapter protein. The assembly
of the NLRP3 inflammasome triggers
caspase-1 activation leading to process-
ing of interleukin-1ß (IL-1ß) (Schroder
and Tschopp, 2010).
Studies by Shimada et al. and Saxena
et al. elucidate the mystery of inflamma-
some activation that could hold a key to a
therapeutic approach to limit unchecked
cell apoptosis and inflammation with lim-
ited side effects. Shimada et al. reported
that oxidized mitochondrial DNA
(mtDNA) directly activates the NLRP3
inflammasome (Shimada et al., 2012).
Their work showed that direct binding
of oxidized mtDNA with NLRP3 serves
as a trigger for inflammasome activation,
indicating that apoptosis signaling leads
to inflammasome activation and IL-1ß
secretion. A key signaling point occurs
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when mtDNA reacts with ROS to become
oxidized mtDNA, threatening imminent
cell death (Shimada et al., 2012). Earlier,
Nakahira et al. showed that mtDNA inter-
acts with NLRP3 (Nakahira et al., 2011)
but the exact mechanism is unknown.
Significant cytosolic levels of free oxidized
mtDNA could not be found in the absence
of NLRP3, suggesting that it may stabi-
lize mtDNA. As mentioned earlier, Saxena
et al. described a novel mitochondrial
apoptosis signaling cascade showing that
TXNIP, under oxidative stress, translocates
from the nucleus to mitochondria (Saxena
et al., 2010). It is therefore tempting to
speculate that mitochondrial shuttling of
TXNIP may affect mitochondrial dysfunc-
tion and oxidation of mtDNA leading
to NLRP3 inflammasome activation.
Exploration of TXNIP’s role in the mito-
chondria, interactions with mitochondrial
TRX2 and mitochondrial danger signaling
has shed light on a new NLRP3 signaling
pathway not previously described.
ROS within mitochondria must initi-
ate the mitochondrial cascade upstream,
causing inflammasome activation. Several
studies show that mitochondrial ROS are
present prior to NLRP3 activation (Zhou
et al., 2011). A possible source of ROS
could stem from early TXNIP transloca-
tion following upstream cellular oxidative
stress signals (Figure 1). Mitochondrial
shuttling of TXNIP, followed by displace-
ment of ASK1 by TXNIP-TRX2 binding,
initiates downstream apoptotic signaling.
Also, TXNIP inhibits TRX2 protection of
mitochondria against ROS, allowing free
oxidation of mtDNA, signaling distress,
binding NLRP3, and triggering inflam-
masome activation. Downstream cleavage
of caspase-3 by ASK1 leads to apoptosis
serving as a secondary signal for NLRP3
activation.
Based on the mechanisms described,
early apoptotic signals play a crucial role in
inflammation. The earliest signal found is
the shuttling of TXNIP from the nucleus
to the mitochondria. A key therapeutic
approach to limit inflammasome activa-
tion could be to inhibit mitochondrial
shuttling of TXNIP. It was previously
discussed that TXNIP inhibits reductive
properties of TRX. In the mitochondria,
this inhibition allows ROS to accumulate
until TXNIP is shuttled to the cytoplasm
where it interacts with NLRP3 (Davis
and Ting, 2010). However, this mecha-
nism needs to be defined. The increase
in ROS causes the release of oxidized
mtDNA, cytochrome C, and caspase-3
cleavage. Combined, these signals induce
cell apoptosis and inflammasome activa-
tion, leading to IL-1ß secretion and local-
ized inflammation. When TXNIP is in
the mitochondria, it allows the accumula-
tion of ROS. Therefore, finding and block-
ing the shuttling mechanism for TXNIP
would allow TRX2 to maintain its reduc-
tive role and prevent downstream activa-
tion of NLRP3.
The role of TXNIP in inflammasome
activation has proven invaluable in efforts
to limit damage to cells and surrounding
tissue. Once TXNIP reaches themitochon-
dria, it triggers a rapid cascade of apoptotic
signals that end with TXNIP-NLRP3 bind-
ing and inflammasome activation. Early
warning signals may be present prior
to TXNIP translocation to mitochondria;
however, such signals need to be iden-
tified. Further investigations into TXNIP
localization and mitochondrial shuttling
should be undertaken to completely map
FIGURE 1 | Oxidative stress mediated TXNIP shuttling: TXNIP
localization under basal conditions (Left), TXNIP rests in the nucleus.
TRX1-ASK1 binding in the cytosol and TRX2-ASK1 binding in the mitochondria
maintains low ROS. Under oxidative stress (Right), TXNIP shuttles to the
cytosol and mitochondria where it binds TRX1 and TRX2, respectively. ROS
builds up, initiating mitochondrial distress signaling and eventual apoptotic
cascade. It is unknown by what mechanism TXNIP shuttles to the
mitochondria during oxidative stress.
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the signaling pathway, find factors that
block TXNIP, and ultimately limit undesir-
able inflammasome activation.
In recent years, there is continued evi-
dence of the central role of inflammasomes
in sensing danger signals and orchestrat-
ing a subsequent inflammatory program
(Kolliputi et al., 2010). However, due to the
multitude of danger signals sensed by the
NLRP3 inflammasome, it has remained a
mystery how a single molecule can achieve
this almost impossible task. A plausible
explanation is that instead of detecting
each danger signal individually, theNLRP3
inflammasomemonitors the activity of the
mitochondrion, which acts as an integra-
tor of danger signals, including those of
metabolic origin. Via a mechanism that
remains elusive, excessive ROS produc-
tion by mitochondria leads to activation
of the inflammasome. Therefore, a clear
understanding of this mechanism and reg-
ulation, will allow development of new
therapeutic approaches to diseases involv-
ing the NLRP3 inflammasome.
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